BibTex Citation Data :
@article{JIAB29801, author = {Afiani Wulandari and Dinalestari Purbawati}, title = {The Influence of Intellectual Capital on Firm Value through Financial Performance as an Intervening Variable (Study on Pharmaceutical Sub-Sector Companies Listed on the Indonesia Stock Exchange Periode 2016 - 2019)}, journal = {Jurnal Ilmu Administrasi Bisnis}, volume = {10}, number = {1}, year = {2021}, keywords = {intellectual capital, financial performance, and firm value}, abstract = { The formation of a company is due to the objectives to be achieved, one of which is maximizing company value. Firm value is a reflection of the company's performance which is formed by supply and demand in the capital market which can be influenced by several factors, including intellectual capital and financial performance. This study aims to examine the effect of intellectual capital on firm value through financial performance as an intervening variable in pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange for the period 2016 – 2019. The data used is secondary data derived from the publication of financial reports by the IDX. The analysis method used is regression analysis and single test. The results showed that simultaneously intellectual capital and financial performance had a significant effect on company value, partially intellectual capital had no effect on company value, intellectual capital had no effect on financial performance, financial performance had no effect on firm value, and financial performance was not an intervening variable between intellectuals. capital and financial performance. It is recommended that pharmaceutical companies optimize their intellectual capital and financial performance so as to increase company value to convince investors. Investors are advised before placing their funds to consider intellectual capital, financial performance and other external factors that may affect company value. }, issn = {2746-1297}, pages = {793--802} doi = {10.14710/jiab.2021.29801}, url = {https://ejournal3.undip.ac.id/index.php/jiab/article/view/29801} }
Refworks Citation Data :
The formation of a company is due to the objectives to be achieved, one of which is maximizing company value. Firm value is a reflection of the company's performance which is formed by supply and demand in the capital market which can be influenced by several factors, including intellectual capital and financial performance. This study aims to examine the effect of intellectual capital on firm value through financial performance as an intervening variable in pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange for the period 2016 – 2019. The data used is secondary data derived from the publication of financial reports by the IDX. The analysis method used is regression analysis and single test. The results showed that simultaneously intellectual capital and financial performance had a significant effect on company value, partially intellectual capital had no effect on company value, intellectual capital had no effect on financial performance, financial performance had no effect on firm value, and financial performance was not an intervening variable between intellectuals. capital and financial performance. It is recommended that pharmaceutical companies optimize their intellectual capital and financial performance so as to increase company value to convince investors. Investors are advised before placing their funds to consider intellectual capital, financial performance and other external factors that may affect company value.
Note: This article has supplementary file(s).
Article Metrics:
Last update:
Copyright of all published articles is retained by the respective author(s). Authors grant Jurnal Ilmu Administrasi Bisnis a non-exclusive license to publish the article and to identify itself as the original publisher. This license also includes the right for the journal to distribute the article as part of its publication, including in printed or electronic formats, for non-commercial dissemination.
All articles published Open Access will be immediately and permanently free for everyone to read and download. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows: Creative Commons-Non Ceomercial-Attribution-ShareAlike (CC BY-SA)